← back to search

Alexandra Rizos

Parkinson's UK ·
Area of research
Neurology · Epidemiology
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Parkinson's Disease and Spinal Disorders, and Restless Legs Syndrome Research.
h-index
38
citations
3,940
works
116
NIH funding
primary concept
email

Recent publications

Effects of a Four‐Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial
Movement Disorders 2025cited by 6position: middledoi
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years
JAMA Network Open 2024cited by 38position: middledoi
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
npj Parkinson s Disease 2024cited by 13position: middledoi
Non-motor effects of deep brain stimulation in Parkinson's disease motor subtypes
Parkinsonism & Related Disorders 2023cited by 21position: middledoi
Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
npj Parkinson s Disease 2022cited by 64position: middledoi
Gender gap in deep brain stimulation for Parkinson’s disease
npj Parkinson s Disease 2022cited by 59position: middledoi
Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life
Scientific Reports 2021cited by 52position: middledoi
Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease
npj Parkinson s Disease 2021cited by 44position: middledoi
The Parkinson disease pain classification system: results from an international mechanism-based classification approach
Pain 2020cited by 97position: middledoi
Prevalence of Non‐Motor Symptoms and Non‐Motor Fluctuations in Parkinson's Disease Using the <scp>MDS‐NMS</scp>
Movement Disorders Clinical Practice 2020cited by 81position: middledoi
Drooling in Parkinson’s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study
Dysphagia 2020cited by 73position: middledoi
A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson’s disease: results at the 36-month follow-up
Journal of Neurology Neurosurgery & Psychiatry 2020cited by 67position: middledoi
Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson’s disease
Brain stimulation 2020cited by 63position: middledoi
Dementia in long-term Parkinson’s disease patients: a multicentre retrospective study
npj Parkinson s Disease 2020cited by 54position: middledoi
Subthalamic Stimulation Improves Quality of Sleep in Parkinson Disease: A 36-Month Controlled Study
Journal of Parkinson s Disease 2020cited by 41position: middledoi
Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson’s disease
Journal of Neurology 2020cited by 35position: middledoi
EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
Movement Disorders 2019cited by 182position: middledoi
Non-motor outcomes depend on location of neurostimulation in Parkinson’s disease
Brain 2019cited by 163position: middledoi
The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study
Movement Disorders 2019cited by 120position: middledoi
Pilot Study of the International Parkinson and Movement Disorder Society‐sponsored Non‐motor Rating Scale (MDS‐NMS)
Movement Disorders Clinical Practice 2019cited by 62position: middledoi
Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease
Journal of Neurology 2019cited by 40position: middledoi
Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease
Movement Disorders 2018cited by 97position: middledoi
Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts
Brain stimulation 2018cited by 78position: middledoi
Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease
Brain stimulation 2018cited by 50position: middledoi
First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire
European Journal of Neurology 2018cited by 40position: middledoi
Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease
Movement Disorders Clinical Practice 2018cited by 31position: middledoi
Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale
npj Parkinson s Disease 2017cited by 54position: middledoi
Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age
Movement Disorders 2017cited by 52position: middledoi
Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson’s disease
Scientific Reports 2017cited by 41position: middledoi
Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson’s Disease
Neuromodulation Technology at the Neural Interface 2017cited by 35position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

К. Ray Chaudhuri · UK Dementia Research Institute35 papers (2012–2023)Pablo Martínez‐Martín · University of Rochester32 papers (2012–2023)Angelo Antonini · Delft University of Technology21 papers (2012–2023)Monty Silverdale · University of Manchester16 papers (2014–2023)Anna Sauerbier · University of Cologne13 papers (2014–2023)Julian Evans · University of Manchester12 papers (2017–2023)Keyoumars Ashkan · King's College - North Carolina12 papers (2017–2023)Veerle Visser‐Vandewalle · University of Padua12 papers (2017–2023)Haidar S. Dafsari · University of Cologne12 papers (2017–2023)Lars Timmermann · Berlin Institute of Health at Charité - Universitätsmedizin Berlin10 papers (2017–2023)Per Odin · Lund University10 papers (2012–2019)Michael T. Barbe · University of Cologne8 papers (2017–2023)Gereon R. Fink · European Academy of Neurology8 papers (2017–2023) · 6 papers (2015–2021)Michael Samuel · NewYork–Presbyterian Hospital6 papers (2017–2020) · 6 papers (2020–2023) · 5 papers (2014–2018) · 5 papers (2018–2020) · 5 papers (2017–2020)Cristian Falup‐Pecurariu · Florida International University5 papers (2015–2021)